🇺🇸 FDA
Pipeline program

warfarin

CV185-030

Phase 3 small_molecule completed

Quick answer

warfarin for Atrial Fibrillation is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Bristol-Myers Squibb
Indication
Atrial Fibrillation
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials